Broker Recommendations
Jefferies upgrades Anglo American, BHP, Rio Tinto
Jefferies upgraded its stance on shares of Anglo American, BHP and Rio Tinto on Tuesday and lifted its iron and coal price forecasts as it took a look at the mining sector, arguing that it was undervalued and poised to recover.
Berenberg stays at 'buy' for AstraZeneca after trial results for Enhertu against breast cancer
Analysts at Berenberg reiterated their 'buy' recommendation with a 120. 0p target price for shares of AstraZeneca following the release of the company's clinical trial results for its treatment against metastatic breast cancer.
Barclays downgrades Enquest to 'underweight' due to government levy
Analysts at Barclays downgraded their recommendation for shares of Enquest on the back of the government's recently announced plan for a levy on energy companies' profits.
RBC hikes FirstGroup target price, says I Squared offer undervalues company
Analysts at RBC hiked their target price for shares of First Group on the back of improved estimates for the company's UK bus and rail franchise.
JP Morgan thinks risk-reward for equities will likely improve going into 2H
Equity strategists at JP Morgan sounded a relatively upbeat note on the outlook for stocks globally.
Berenberg lowers target price on Impax Asset Management
Analysts at Berenberg lowered their target price on asset manager Impax from 1,350. 0p to 1,250. 0p on Wednesday as ongoing market volatility had somewhat offset the firm's "strong H1 results".
Deutsche Bank upgrades B&M to 'hold', lowers target price
Analysts at Deutsche Bank upgraded their rating on retailer B&M from 'sell' to 'hold' on Wednesday, stating earnings risks were increasing but valuation upside was also present.